We are live on
!
Find out more
PHS
PFM Health Sciences Portfolio holdings
AUM
$1.1B
1-Year Est. Return
57.92%
This Fund
S&P 500
This Quarter
Est. Return
+9.38%
1 Year Est. Return
+57.92%
3 Year Est. Return
+183.93%
5 Year Est. Return
+283%
10 Year Est. Return
+2,507.28%
AUM
$5B
AUM Growth
-$515M
(-9.3%)
Cap. Flow
-$868M
Cap. Flow
% of AUM
-17.36%
Top 10 Holdings %
Top 10 Hldgs %
42.58%
Holding
90
New
18
Increased
21
Reduced
23
Closed
27
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
RAD
Rite Aid Corporation
RAD
|
+$221M |
| 2 |
Netflix
NFLX
|
+$154M |
| 3 |
AGN
Allergan Inc
AGN
|
+$138M |
| 4 |
Martin Marietta Materials
MLM
|
+$125M |
| 5 |
Vulcan Materials
VMC
|
+$121M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$439M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$401M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$230M |
| 4 |
ENDP
Endo International plc
ENDP
|
+$155M |
| 5 |
Workday
WDAY
|
+$122M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 37.84% |
| 2 | Communication Services | 11.85% |
| 3 | Materials | 8.94% |
| 4 | Consumer Discretionary | 8.09% |
| 5 | Technology | 7.53% |
Similar funds
DAM
MAM
CPRC
AWP
LCM
PRS
DAM
KCM
PFM Health Sciences's Q2 2014 Portfolio in Review
As of Q2 2014, PFM Health Sciences held 90 positions worth $5B, down 9.3% from $5.52B the previous quarter. Its ten largest holdings account for 43% of the portfolio.
PFM Health Sciences withdrew a net $868M in Q2 2014, closing 27 positions and reducing 23 holdings. Its most notable exit was iShares MSCI Emerging Markets ETF, an estimated $439M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 38% of assets, down from 46% a quarter earlier, followed by Communication Services and Materials.
Against the trend, PFM Health Sciences opened a new position in Netflix worth $179M.
- PFM Health Sciences's largest Q2 2014 buy was Netflix: 28,445,060 shares worth $179M.
- PFM Health Sciences added most to Rite Aid Corporation in Q2 2014, an estimated $221M increase.
- PFM Health Sciences's biggest Q2 2014 reduction was Alphabet (Google) Class C, cutting an estimated $230M.
- PFM Health Sciences fully exited iShares MSCI Emerging Markets ETF in Q2 2014, selling an estimated $439M.
- PFM Health Sciences's ten largest holdings make up 43% of its $5B portfolio in Q2 2014.
- PFM Health Sciences opened 18 new positions and closed 27 in Q2 2014.
- PFM Health Sciences's portfolio value fell 9.3% quarter-over-quarter to $5B.
Based on PFM Health Sciences's 13F filing for Q2 2014, filed 14 Aug 2014.